Cargando…
Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
Metformin, a biguanide derivate, has pleiotropic effects beyond glucose reduction, including improvement of lipid profiles and lowering microvascular and macrovascular complications associated with type 2 diabetes mellitus (T2DM). These effects have been ascribed to adenosine monophosphate-activated...
Autores principales: | Napolitano, Antonella, Miller, Sam, Nicholls, Andrew W., Baker, David, Van Horn, Stephanie, Thomas, Elizabeth, Rajpal, Deepak, Spivak, Aaron, Brown, James R., Nunez, Derek J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079657/ https://www.ncbi.nlm.nih.gov/pubmed/24988476 http://dx.doi.org/10.1371/journal.pone.0100778 |
Ejemplares similares
-
Gut microbiome differences between metformin‐ and liraglutide‐treated T2DM subjects
por: Wang, Zhang, et al.
Publicado: (2017) -
Correction: Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
Publicado: (2014) -
Selective Spectrum Antibiotic Modulation of the Gut Microbiome in Obesity and Diabetes Rodent Models
por: Rajpal, Deepak K., et al.
Publicado: (2015) -
Gut Hormone Pharmacology of a Novel GPR119 Agonist (GSK1292263), Metformin, and Sitagliptin in Type 2 Diabetes Mellitus: Results from Two Randomized Studies
por: Nunez, Derek J., et al.
Publicado: (2014) -
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang, Qi, et al.
Publicado: (2020)